Amundi Asset Management US’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$16M Buy
97,625
+38,380
+65% +$6.31M 0.01% 725
2020
Q4
$9.78M Sell
59,245
-7,644
-11% -$1.26M 0.01% 815
2020
Q3
$9.54M Buy
66,889
+7,411
+12% +$1.06M 0.01% 742
2020
Q2
$6.56M Buy
59,478
+8,013
+16% +$884K 0.01% 799
2020
Q1
$5.13M Sell
51,465
-107,252
-68% -$10.7M 0.01% 726
2019
Q4
$23.7M Buy
158,717
+18,559
+13% +$2.77M 0.03% 504
2019
Q3
$18M Sell
140,158
-150,126
-52% -$19.2M 0.03% 541
2019
Q2
$41.4M Sell
290,284
-120,710
-29% -$17.2M 0.03% 370
2019
Q1
$58.8M Buy
410,994
+39,812
+11% +$5.69M 0.08% 247
2018
Q4
$46K Buy
371,182
+147,419
+66% +$18.3K 0.04% 270
2018
Q3
$37.6M Sell
223,763
-24,687
-10% -$4.15M 0.05% 350
2018
Q2
$42.8M Sell
248,450
-185,561
-43% -$32M 0.06% 315
2018
Q1
$65.5M Sell
434,011
-215,508
-33% -$32.5M 0.11% 206
2017
Q4
$87.5M Sell
649,519
-241,803
-27% -$32.6M 0.13% 171
2017
Q3
$130M Buy
891,322
+54,895
+7% +$8.03M 0.42% 74
2017
Q2
$130M Buy
836,427
+127,551
+18% +$19.8M 0.43% 63
2017
Q1
$103M Sell
708,876
-113,811
-14% -$16.5M 0.35% 79
2016
Q4
$89.7M Buy
822,687
+178,904
+28% +$19.5M 0.32% 79
2016
Q3
$78.2M Buy
643,783
+171,694
+36% +$20.9M 0.28% 86
2016
Q2
$66.7M Buy
472,089
+9,629
+2% +$1.36M 0.24% 98
2016
Q1
$60.4M Buy
462,460
+98,661
+27% +$12.9M 0.22% 100
2015
Q4
$51.1M Buy
363,799
+29,151
+9% +$4.1M 0.19% 121
2015
Q3
$44.4M Buy
334,648
+12,324
+4% +$1.64M 0.18% 134
2015
Q2
$56.8M Sell
322,324
-608
-0.2% -$107K 0.21% 132
2015
Q1
$55.8M Buy
322,932
+69,089
+27% +$11.9M 0.2% 127
2014
Q4
$41.6M Sell
253,843
-57,161
-18% -$9.36M 0.15% 167
2014
Q3
$49.9M Sell
311,004
-588
-0.2% -$94.4K 0.19% 144
2014
Q2
$45.8M Buy
311,592
+42,923
+16% +$6.31M 0.18% 160
2014
Q1
$37.3M Buy
268,669
+26,842
+11% +$3.72M 0.14% 177
2013
Q4
$30.6M Sell
241,827
-86,551
-26% -$11M 0.12% 196
2013
Q3
$30.2M Sell
328,378
-92,681
-22% -$8.52M 0.12% 193
2013
Q2
$28.9M Buy
+421,059
New +$28.9M 0.12% 208